Grants

​​​​​ATTD START-UP GRANTS

​ATTD is delighted to announce the introduction of its ATTD Start-Up Grants​ to be offered to 10 outstanding start-up companies presenting an innovative product currently in the pipeline. Apply to receive a €2,500 grant (plus further benefits) and participate at the prestigious International Fair of New Technologies during ATTD 2017, taking place in Paris, France, 15-18, 2017. 


Meet the Experts. Discover the Latest Research. Behold the Next Big Thing. The International Fair of New Technologies in Diabetes: where start-ups and emerging companies will be displaying cutting edge technologies and medical devices for diabetes treatment. Be at ATTD 2017, the forefront of this constantly evolving discipline. 
  
For more information click h​ere​​.

Diabetes Innovation Challenge presented by T1D Exchange and M2D2

T1D Exchange (non-profit organization driving faster, better research in type 1 diabetes) and M2D2 (a joint venture of University of Massachusetts Lowell and Worcester campuses that incubates medical device start-ups) announce the Diabetes Innovation Challenge.

This is an open competition to identify and accelerate transformational advancements in type 1 and type 2 diabetes research and care. Specifically, this competition seeks both pre-clinical and translational next-generation opportunities in the following categories:

  • Devices – such as novel glucose sensing, insulin delivery, cellular therapy delivery technologies
  • Diagnostics – such as novel low costs tests for research and screening: early diagnosis – prevention; autoantibodies, C-Peptide or other markers such as beta cell death and risk of diabetic complications
  • Therapeutics – such as smart insulins, glucagons, immune modulating, beta-cell regeneration
  • Technologies  – such as and disruptive approaches to use of information on and communication technologies to support diabetes management, range of hardware and software applications (patient or clinician) ,decision support, algorithms, and mobile applications

The Diabetes Innovation Challenge will provide up to two awards of up to $150,000 in cash or in-kind services provided by T1D Exchange, M2D2, and challenge sponsors, including JDRF, the leading global organization funding type 1 diabetes research program sponsors.  

Applications can be submitted until July 11th.

Submit an application: Request for Application website  

Register to attend a Challenge events


Keep Me Updated